Novel 1,4-Diazepane derivatives as amyloid-beta (Aβ) aggregation inhibitors

Rahul C. Karuturi, Ahmed A. Hefny, Arash Shakeri, Praveen P. N. Rao · 2026

Read Novel 1,4-Diazepane derivatives as amyloid-beta (Aβ) aggregation inhibitors by Rahul C. Karuturi, Ahmed A. Hefny, Arash Shakeri, Praveen P. N. Rao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13574327.txt.

Description

In Alzheimer's disease, the amyloid-beta peptide clumps into toxic aggregates, and Rahul Karuturi and three co-authors design small molecules to stop the clumping. Their series is built on a flexible seven-membered ring called 1,4-diazepane, varied across fourteen compounds and screened against both major forms of the peptide with a fluorescence assay.

One compound led against the more toxic form, blocking forty-two percent of aggregation at the test dose, while two others blocked both forms, reaching the high fifties against the shorter peptide. The leading trio also protected mouse brain cells from peptide damage, and one added antioxidant power. Electron microscopy and computer docking suggested the molecules grip both ends of the peptide and stabilize harmless assemblies. The authors name the ring a new scaffold for anti-amyloid drug design.

Catalog record

CREATORRahul C. Karuturi, Ahmed A. Hefny, Arash Shakeri, Praveen P. N. Rao
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13574327

Browse the full library · About the Tower of Babel